Skip to main content
. 2019 Feb 7;11(2):70. doi: 10.3390/pharmaceutics11020070

Table 1.

Incidence of granulomatous hepatitis or granulomatous splenitis.

Abnormality No treatment % PLGA TAA % PEA TAA %
granulomatous hepatitis no–slight reaction (2/6) 33 no–slight reaction (3/6) 50 no–slight reaction (5/6) 83
moderate reaction (1/6) 17 moderate reaction (1/6) 17
severe reaction (3/6) 50 severe reaction (2/6) 33 severe reaction (1/6) 17
granulomatous splenitis no–slight reaction (2/6) 33 no–slight reaction (2/6) 33
severe reaction (4/6) 67 severe reaction (6/6) 100 severe reaction (4/6) 67